Cargando…
Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
Conventional non-surgical therapeutic regimens against osteosarcoma are subject to chemoresistance and tumor relapse, and immunotherapy may be promising for this tumor. However, it's hard to find satisfactory epitopes for immunotherapy against osteosarcoma. Cancer/testis antigens (CTAs), such a...
Autores principales: | Li, Binghao, Zhu, Xiaobing, Sun, Lingling, Yuan, Li, Zhang, Jian, Li, Hengyuan, Ye, Zhaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279410/ https://www.ncbi.nlm.nih.gov/pubmed/25301731 |
Ejemplares similares
-
Valproic Acid Combined with Zoledronate Enhance γδ T Cell-Mediated Cytotoxicity against Osteosarcoma Cells via the Accumulation of Mevalonate Pathway Intermediates
por: Wang, Shengdong, et al.
Publicado: (2018) -
Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
por: Wang, Zhan, et al.
Publicado: (2018) -
Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma
por: Hu, Keqi, et al.
Publicado: (2017) -
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
por: Wang, Zhan, et al.
Publicado: (2016) -
Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed Tomography
por: Wu, Yan, et al.
Publicado: (2018)